The failure to have a complete recovery from early relapses in multiple sclerosis (MS) is significantly associated with higher long-term disability and should be given more consideration when evaluating outcomes both in research and clinical practice, a new study suggests.

“We found that the recovery from early relapses is an important predictor of future disability and it should be incorporated in future predictive models of disease severity and clinical trials, while it could be useful in clinical decision-making as well,” first author Marinos G. Sotiropoulos, MD, of the Department of Neurology, Brigham and Women’s Hospital, Boston, says in a media release from Medscape Medical News.

Read the full article at